Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by krbcanon Jul 01, 2017 1:56pm
164 Views
Post# 26427376

RE:I guess I was wrong

RE:I guess I was wrong
bionicjoe wrote: I thought this AGM would put to rest a lot of important questions dogging shareholders of late. Top on the list is if the company will for sure put out a PR soon after the cystoscopy examinations of the first 3 patients are due? I hate to break it to skier59 but the market doesn't really care what kind of beer he is taking to his Canda Day party but it is acutely receptive to knowing if in fact there will be a report issued on the potential first signs of efficacy and if it will be in July? Why is it that the day after the AGM there still is no clarity even though the meeting was attended by regular contributors to this SH board? Many other issues of vital concern to shareholders remain unanswered but the efficacy question is naturally what the sp will key on in the next few weeks. Yet no one thought to ask RW or Dr. Kulkarni if a report was forthcoming in July? AGM's are about taking care of business both for management and for shareholders. If as a shareholder you failed to do that then I consider it a long way to travel just to have a meal and a beverage with the boss of TLT. If after going through the time & expense of attending the AGM you come away no wiser than what was the point of going?


Dennis, you aren't even a shareholder.  Why are you so concerned about what came up at the AGM?  Why didn't you show up at AGM personally if you have so many questions that you absolutely need answers?

No one wants to share details of the AGM with you by PM and/or other attendees are too busy today on a holiday weekend to post here. Stop trying to spin this into a negative. It is tiresome and entirely obvious what you are up to.

You've already posted 10 times today so you are looking even more desperate than normal, and just further reflects the sad reality of your life and your chronic presence here day after day after day. 

Bullboard Posts